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Abstract
Background Gastrointestinal infections are caused by a
broad spectrum of pathogens. Conventional diagnostic
procedures are resource and time consuming due to single
pathogen testing, often in different laboratories.
Method We analyzed 312 consecutive stool samples from
pediatric patients (n = 127) with gastroenteritis or from
adult travelers returning from the tropics with suspected
parasite infestation (n = 185) using commercial multiplex
nucleic acid amplification testing (NAT) (xTAG gastroin-
testinal pathogen panel, Luminex) covering 15 diarrhea-
causing pathogens. The results of the positive samples and
a representative number of negative samples were com-
pared to standard methods, including NAT, direct antigen
detection (DAD), bacterial culture and microscopy.
Results Of the 185 samples from adult travelers, 21
(11 %) were multiplexNAT-positive, with enterotoxi-
genic Escherichia coli (4 %) being the predominant
pathogen. Microscopic examination revealed Blastocystis
hominis in 23 % not covered by the panel. Multiplex-
NAT scored positive in 66 pediatric samples (52 %),
with rotavirus (27 %) being the most prevalent. All
adenovirus-, rotavirus-, Clostridium difficile- and Cryp-
tosporidium-positive samples were confirmed in external
laboratories, but only 40 % of norovirus- and 29 % of
Giardia-positive samples. Analysis of frozen specimens
by bacterial culture showed the highest discrepancies
with the multiplexNAT.
Conclusion Our study demonstrates broad detection of
relevant gastroenteritis pathogens by multiplexNAT with a
short turnaround time. This is important for diagnosis,
infection control and empiric management of gastroenter-
itis patients, but may be selectively complemented by
bacterial culture and resistance testing.
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Introduction
Acute gastroenteritis is a major health problem worldwide.
Globally, diarrheal disease was responsible for about 0.75
million fatalities in young children in 2010 [22]. While
deaths from diarrhea in industrialized nations are less
common, it remains an important cause of morbidity in
younger children as well as in adults returning from trop-
ical countries. Accordingly, gastrointestinal diseases result
in substantial medical and healthcare expenses, lost pro-
ductivity, and other costs to society and families [15, 33].
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Virus, bacteria and parasite infections are typical causes
of gastrointestinal disease [40]. The standard methods for
detecting these agents are commonly based on microscopy,
culture-based identification and direct antigen detection
(DAD). However, time-consuming parallel testing for all
possible pathogens may be required. A more rapid identi-
fication is desirable, especially since a shorter turnaround
time could reduce nosocomial transmissions by facilitating
infection control measures and specific treatment e.g. for
norovirus or Clostridium difficile [9]. Recently, nucleic
acid amplification testing (NAT) has been developed for
pathogen detection in stool samples, which may permit
parallel testing for multiple pathogens by multiplexing and
reducing the turnaround time to \6 h. In this study, we
examined the performance of a commercial multiplexNAT
called the xTAG GPP (Luminex) using automated nucleic
acid extraction and the MAGPIX platform for the detection
of viruses, parasites and bacteria in 312 consecutive stool
specimens from symptomatic pediatric patients (n = 120)
and travelers returning from the tropics (n = 176).
Materials and methods
Study design
In total, 312 consecutive stool samples from 296 patients
were collected between February 2012 and October 2012.
The pediatric group consisted of 120 patients who pre-
sented with acute gastroenteritis to the emergency room or
were admitted to the University Children’s Hospital Basel
with suspected viral gastroenteritis. The second group
consisted of 151 adult and 25 pediatric patients (n = 176)
returning from the tropics with gastrointestinal symptoms
or parasite infestation submitted by general practitioners
from all over Switzerland. The study was approved by the
Medical Ethical Committee Basel (EKBB Ref No. 242/12).
Demographics and clinical specimens
The 127 pediatric stool samples were obtained from 120
patients (77 males and 43 females; median age 1 year;
interquartile range (IQR) 0 and 2 years; range 6 days to
21 years). The interquartile range is a measure of statistical
dispersion being equal to the difference between the upper
and the lower quartiles IQR = Q3 - Q1. The 185 stool
samples from travelers were obtained from 176 patients (78
males, 98 females; median age 40; IQR 28 and 53 years;
range 2–78 years; Table 1). All samples were aliquoted
and frozen at -80 C and then analyzed by multiplexNAT.
All multiplexNAT-positive samples and a random selec-
tion of 72 multiplexNAT-negative samples were sent
blinded to external laboratories for independent analysis.
Sample pre-treatment and nucleic acid extraction
Native stool samples (50 mg) were transferred from sterile
containers to Bertin SK38 soil kit bead tubes (Bertin
Technologies, Montigny, France), which contain a mix of
glass and ceramic beads in 2 ml standard tubes. After
adding 1 ml of NucliSENS easyMAG lysis buffer (bio-
Me´rieux, Gene`ve, Switzerland) and 10 ll of Escherichia
coli phage MS2 (Luminex Molecular Diagnostics Inc.,
Toronto, Canada) to monitor the efficiency of nucleic acid
extraction and amplification, the tubes were vortexed for
5 min, incubated at room temperature for 10 min and then
centrifuged at 14,000 rpm for 2 min to pellet insoluble
material. 500 ll of the supernatant was transferred to the
extraction tubes (Abbott Molecular, Baar, Switzerland).
Total nucleic acids were extracted from 200 ll of
supernatant using the Abbott m2000sp instrument (Abbott
Molecular, Baar, Switzerland) and the Sample Preparation
SystemDNA Kit according to the Open-Mode-Protocol for
DNA/RNA (RNADNA-Plasma-LL-200-70) of the manu-
facturer’s instructions. The DNA/RNA extract was eluted
into 70 ll of mElution BufferDNA, of which 10 ll was used
immediately for the multiplex RT-PCR. The remaining
extracts were stored at -80 C until further use.
MultiplexNAT
Total nucleic acids extracted from fecal samples were
analyzed by multiplexNAT using the xTAG Gastrointes-
tinal Pathogen Panel assay (Luminex Molecular Diagnos-
tics Inc., Toronto, Canada) according to the manufacturer’s
Table 1 Demographic characteristics of the patients
Parameter No. of patients (%)
All patients 296
Gender, male/female 155 (52)/141 (48)
Age range 0–78
Pediatric patients 120
Gender, male/female 77 (64)/43 (36)
Age
0–1 47
1–5 54
5–21 19
Patients returning from tropics 176
Gender, male/female 78 (44)/98 (56)
Age
0–1 0
1–5 5
5–21 20
21–65 133
[65 18
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instructions. The multiplexNAT simultaneously detects 15
pathogens consisting of Salmonella sp., Shigella sp., Shiga
toxin-producing E. coli (STEC) stx1/stx2, Vibrio cholerae,
Yersinia enterocolitica, C. difficile toxin A/B, Campylo-
bacter sp., E. coli O157, Enterotoxigenic E. coli (ETEC)
LT/ST, adenovirus 40/41, rotavirus A, norovirus GI/GII,
Giardia lamblia, Cryptosporidium sp. and Entamoeba
histolytica. Technically, a multiplex reverse transcriptase
PCR is done using target-specific tagged primers and bio-
tinylated primers. Amplification products are detected by
hybridization to the pathogen-specific complementary anti-
tag sequence coupled to specific beads and binding of the
streptavidin–phycoerythrin reporter to the biotinylated
primers. After washing steps, the resulting median fluo-
rescence intensities (MFI) were analyzed by the Luminex
MAGPIX instrument and TDAS software version 1.0. An
MFI value above the threshold for a particular pathogen
and a S/N ratio above 10 indicated a positive result. The
limit of detection (LOD) was evaluated by the manufac-
turer for each pathogen and can be taken from the
instruction manual. Intra-assay reproducibility was asses-
sed using 11 stool samples analyzed on two different days
and revealed 100 % concordance for all samples.
Direct antigen detection (DAD)
Direct antigen detection for rotavirus, adenovirus and
norovirus was performed using the Diarlex Rota–Adeno
latex test (Orion Diagnostica Oy, Espoo, Finland) and the
RIDAQUICK norovirus immunochromatographic lateral
flow test (r-biopharm, Darmstadt, Germany), respectively.
In brief, for the adeno-rotavirus DAD, a 1:10 dilution of
stool specimens in 0.05 M Tris buffer pH 7.2 was vortexed
at room temperature for 2 min, and then centrifuged for
10 min at 1,0009g. Approximately 50 ll of the superna-
tant was gently mixed with an equal volume of the test
latex reagent on a test card. The result was positive if
agglutination occurred within 2 min and no agglutination
was observed with the control latex reagent. For the
norovirus DAD, 0.5 ml of reagent A and 0.5 ml of reagent
B was mixed in a reaction vessel. Approximately 50 ll of
liquid stool or 50 mg of solid stool sample was added to the
reagents to yield a suspension. The suspension was incu-
bated at RT for 5 min. Of the particle-free supernatant,
150 ll was placed into the test cassette. DAD was positive,
if the indicator line and the control line appeared within
15 min.
Parasite detection
All samples from patients returning from the tropics were
examined directly by microscopy after SAF concentra-
tion at a magnification of 5009 for protozoa and a
magnification of 1009 for helminths [24]. For the detection
of Cryptosporidium sp., a smear was read after SAF con-
centration and staining with the modified Ziehl–Neelson
stain [16].
Confirmatory testing
Frozen aliquots of the fecal samples positive for one or
multiple pathogens were sent to different external labora-
tories on dry ice. Samples went through two freeze–thaw
cycles before analysis in the reference laboratory. The
samples were analyzed either by nucleic acid extraction,
followed by a validated PCR or by culture on selective
media for enrichment and identification either with or
without previous priming in adequate enrichment broths.
The C. difficile diagnostics included simultaneous detection
of enterotoxin A/cytotoxin B and glutamate dehydrogenase
(GLDH) antigen using the C. diff Quick Chek Complete kit
(Alere GmBH, Ko¨lm, Germany), and a DNA strip based
technology (Hain Lifescience GmBH, Nehren, Germany)
that allows differentiation of C. difficile, toxin A (tcdA) and
B (tcdB) genes, binary toxin, deletions in regulatory gene
tcdC, as well as detection of moxifloxacin resistance.
External laboratories were the National Reference Center
for Enteropathogenic Bacteria and Listeria (NENT) at the
University of Zu¨rich in Zu¨rich, Switzerland; the Bernhard
Nocht Institute for Tropical Medicine in Hamburg, Ger-
many; the Consulting Laboratory for Rotaviruses and No-
roviruses at the Robert-Koch-Institute in Berlin, Germany;
the National Reference Laboratory for Adenoviruses at the
Institute of Virology of the Hannover Medical School in
Hannover, Germany; and the Consulting Laboratory for C.
difficile at the Institute for Medical Microbiology and
Hygiene, University of the Saarland in Homburg/Saar,
Germany. As negative controls, 72 random samples not
positive in the multiplexNAT analysis were also sent to the
reference laboratories.
MultiplexNAT-positive stool samples detecting Shigella
sp., Salmonella sp., Campylobacter, Shiga toxin-producing
E. coli (STEC) stx1/stx2, or enterotoxigenic E. coli (ETEC)
were thawed and cultured on selective media at the
National Reference Center for Enteropathogenic Bacteria
and Listeria using standard clinical bacteriology [30]. In
brief, for detection of Campylobacter sp, a fecal suspension
was cultured on Brilliance CampyCount agar (Oxoid,
Wesel, Germany) for 48 h at 41.5 C in a microaerophilic
atmosphere. For culture of Salmonella sp., fecal suspension
was grown on MacConkey agar (Oxoid) and after selenite
and Rappaport-Vassiliadis enrichment (Oxoid), on xylose
lysine deoxycholate (XLD) (Oxoid) and mannitol lysine
crystal violet brilliant green (MLCB) (Oxoid) agar plates.
Salmonellae grow as large purple-black colonies due to
hydrogen sulfide production after 18–24 h at 36 C.
Gastrointestinal pathogens in stool samples 963
123
Targets of the commercial multiplex PCR included the
genes for stx1 and stx2 from STEC; the adhesin intimin,
responsible for the intimate attachment to the enterocyte
membrane and the formation of attaching and effacing (A/
E) lesions that is encoded by the eaeA gene, present in
EPEC; the genes for heat-labile (LT) and heat-stable (ST)
enterotoxins of ETEC [31]; and finally the ipaH gene, the
invasion plasmid antigen H that is used for detecting Shi-
gella and EIEC. In addition, the virulence-associated reg-
ulatory genes aggR and agg3C as well as the virulence-
associated plasmid pCVD432 of the EAEC [29], were
targeted in a specific single PCR. The tests were combined
with a commercial multiplex PCR Primer Mix DEC
(Diarrhea-causing E. coli) (Statens Serum Institute, Hil-
lerød, Denmark) specific for stx1, stx2, eaeA, LT, ST and
ipaH to detect STEC, enteropathogenic E. coli (EPEC),
enterotoxigenic E. coli (ETEC), Shigella and enteroinva-
sive E. coli (EIEC), respectively. Furthermore, enteroag-
gregative E. coli (EAEC) were examined by aggR- [5],
pCVD432- [36] and agg3C-specific [3] single PCR anal-
yses. All PCR analyses were performed on colonies grown
on MacConkey agar after 24- and 48-h incubation.
Statistics
Sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) were calculated for
the mulitplexNAT in comparison to DAD, real-time PCR
and bacterial culture using 2 9 2 tables. Agreement
between multiplexNAT, conventional methods and real-
time PCR was assessed by the kappa value test. Kappa
values from 0.21 to 0.4 represent fair agreement; from
0.41 to 0.6 moderate agreement; 0.61 to 0.8 and 0.81 to
0.99 indicate substantial and almost perfect agreement,
respectively.
Results
Of 312 samples, 87 (28 %) were positive by multiplex-
NAT for at least one pathogen. Single infections were
most prevalent as co-infections were found in only eight
samples (3 %; children, 4 %; travelers, 1.6 %). For the
127 samples obtained from the 120 pediatric patients,
multiplexNAT was positive in 66 (52 %) fecal samples.
Thirteen stool samples were tested from six patients
reflecting 11 different episodes, of which only one yielded
a discordant result for norovirus detection. For the 185
samples obtained from the 176 travelers returning from the
tropics, multiplexNAT was positive in 21 (11 %). The
different rates in the two study groups suggested differ-
ences between the patient populations such as age and
exposure risks.
Pediatric patient samples
The pediatric patients either presented to the emergency
room or had been admitted to hospital, and 101 were
younger than 5 years of age (84 %; median age 1 year;
IQR 0 and 1 year; range 6 days to 4 years; Table 1). As a
viral gastroenteritis was suspected on clinical grounds, the
fecal samples were initially analyzed for rotavirus and
adenovirus by DAD. The multiplexNAT panel detected
nine pathogens including rotavirus, norovirus, C. difficile,
Salmonella sp., adenovirus, Campylobacter sp., G. lamblia,
ETEC, and Cryptosporidium sp. (Fig. 1a). Not detected by
multiplexNAT were V. cholerae, Y. enterocolitica, E. his-
tolytica, E. coli STEC, Shigella sp., and E. coli O157. The
seasonal distribution during the 8 months of collection
showed a relative predominance of viral pathogens during
cold season, and bacterial pathogens during the warm
season (Fig. 2).
In the 34 samples found positive for rotavirus by mul-
tiplexNAT, 23 (68 %) samples were also positive for
rotavirus by DAD (Fig. 3). Nine (26 %) of 34 rotavirus-
positive samples were obtained from children \1 year of
age, 21 (62 %) from children between 1 and 2 years of age.
Adenovirus was found by multiplexNAT in four samples,
which were also detected by DAD (100 %). They origi-
nated in three cases from children \2 years of age, and
from one 12-year old child. Of the 11 positive norovirus
samples, only seven had enough material left to be tested
by DAD being positive in three (43 %) specimens (Fig. 3).
Using DAD as reference, the multiplexNAT had a sensi-
tivity of 100 % for rotavirus and adenovirus, and a speci-
ficity of 100 % for adenovirus, and 89.4 % for rotavirus.
For norovirus, the multiplexNAT had a sensitivity of
100 % and a specificity of 96.8 %. No correlation was seen
between level of MFI obtained in the multiplexNAT assay
and detection by the antigen test for rotavirus and norovi-
rus. DAD was used for pediatric samples only, since the
primary indication for testing samples from patients
returning from the tropics was the search for parasitic
disease.
Pathogens in samples of patients returning
from the tropics
The 176 mostly adult travelers consisted of 78 males and
98 females, including 25 children (median age 40; IQR 28
and 53 years; range 2–78 years). In 11 %, multiplexNAT
detected eight different pathogens including ETEC, G.
lamblia, norovirus, Shigella sp., and Campylobacter sp.,
Salmonella sp., adenovirus and C. difficile (Fig. 1b),
whereas rotavirus, Shiga toxin-producing E. coli (STEC),
E. coli O157, V. cholerae, Y. enterocolitica, E. histolytica
and Cryptosporidium sp. were not detected.
964 C. Beckmann et al.
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AB
Fig. 1 Distribution of
pathogens in pediatric samples
and samples from travelers
returning from the tropics
detected by multiplexNAT.
a Distribution of pathogens in
127 pediatric samples collected
from 120 children (5 co-
infections). b Distribution of
pathogens in 185 fecal samples
collected from 176 travelers
returning from the tropics (3 co-
infections)
Fig. 2 Temporal distribution of
infections in pediatric samples
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The 185 fecal samples were initially examined by
microscopy for protozoa and helminths infection (Table 2).
In 63 samples (34 %) a positive result was reported,
with Blastocystis hominis being the most frequently
detected (42/63; 67 %), followed by Endolimax nana
(14/63; 22 %), Entamoeba hartmanni/coli (14/63; 22 %)
and E. histolytica/dispar (9/63; 5 %). Microscopy revealed
12 (6 %) double and 5 (3 %) triple infections; the majority
of them involved B. hominis (12/17; 71 %).
To compare the results of the multiplexNAT with
standard microscopy, only data for the three parasites
included in the panel (G. lamblia, E. histolytica and
Cryptosporidium sp.) could be taken into account
(Table 2). Absence of Cryptosporidium sp. was confirmed
by multiplexNAT, however, four additional cases of G.
lamblia infection were revealed (n = 5; 2.7 %). E. his-
tolytica was not detected by the mulitplexNAT, and the
microscopy-positive results were identified as Entamoeba
dispar, coli and hartmanni.
After introduction of the multiplexNAT assay in our
routine diagnostics, 69 consecutive samples from 43
patients with diarrhea (24 males and 19 females, median
age, 55 years; IQR 44 and 65 years; range 24–79 years)
were analyzed. A positivity rate of 29 % was revealed,
with the leading pathogens being norovirus (10 %), C.
difficile (4 %) and Campylobacter sp. (4 %). Thus, the
distribution was similar to the one found in the pediatric
gastroenteritis patients.
Comparison of the multiplexNAT with conventional
diagnostics
Samples testing positive by multiplexNAT were sent off
for independent blinded testing in different external labo-
ratories. For eight samples, sufficient material was not
available. For the remaining 64, 53 (83 %) were confirmed.
All samples that were sent in for analysis of rotavirus,
adenovirus, Cryptosporidium sp. and C. difficile were
confirmed giving rise to 100 % sensitivity, specificity, PPV
and NPV and a perfect interobserver agreement of j = 1
(Table 3). Additional sequencing of the adenoviral DNA
revealed adenovirus group F, serotype 41 for all adenovi-
rus-positive samples. Adenovirus group F, serotypes 40
Fig. 3 Comparing
MultiplexNAT with virus DAD
and PCR Detection
Table 2 Overview of microscopic results in comparison to
multiplexNAT
Pathogen No. of positives using
microscopy (%)
No. of positives using
multiplexNAT (%)
Protozoans 63 (34) 5 (3)
Blastocystis
hominis
42 (23)
Endolimax nana 14 (8)
Entamoeba
hartmanni/coli
13 (7)
Entamoeba
histolytica/
dispar
9 (5) 0
Jodamoeba
bu¨tschlii
3 (2)
Chilomastix
mesnili
2 (1)
Giardia lamblia 1 (0.5) 5 (3)
Cyclospora 1 (0.5)
Microsporidia 0
Cryptosporidia 0 0
Helminthes 3 (2)
Strongyloides
stercoralis
1 (0.5)
Ascaris
lumbricoides
1 (0.5)
Hookworm
(eggs)
1 (0.5)
Dual infections 12 (6)
Triple infections 5 (3)
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and 41 have been most commonly associated with acute
gastroenteritis in children and adults [38]. Of the 15 mul-
tiplexNAT norovirus-positive samples, only six (40 %)
could be confirmed by real-time PCR. MultiplexNAT
revealed that six of the norovirus-positive samples from
children belonged to genogroup II (GII), three samples to
genogroup I (GI), and two to each genogroup of the four
positive diarrheal samples from patients returning from the
tropics. Two specimens could not be repeated due to lack
of material. Sensitivity for norovirus was calculated to be
100 %, specificity 42 %, the PPV was 46 % with a fair
agreement of j = 0.32. Seven specimens were positive for
G. lamblia by multiplexNAT. Of these, only two tested
positive by real-time PCR (29 %). The MFI values of the
non-confirmed samples ranged from 226 to 878, suggesting
a lower parasitic load. The MFI values of the two positives
specimens were at 1,428 and 1,561, of which the latter was
microscopically positive. Due to lack of specimen, one of
the samples could not be tested by real-time PCR. Sensi-
tivity for G. lamblia was 100 %, specificity 56 %, the PPV
was calculated to be only 33 %; a fair agreement between
real-time PCR and the multiplexNAT assay resulted in j of
0.32 (Table 3).
All C. difficile-positive samples were confirmed by
DNA-hybridization for C. difficile and the toxin A and B
genes, as well as in the C. difficile antigen (GLDH)
assay. The cytotoxin AB test was positive in six out of
nine samples, culture in only three samples. Two of the
culture-positive samples belonged to PCR ribotype 14/66,
one to PCR ribotype 10. Other bacterial pathogens were
detected by multiplexNAT in 10 stool samples from
children (8 %) and 11 samples from travelers returning
from the tropics (6 %). These 21 positive specimens
were found positive for ETEC LT/ST (n = 8), Cam-
pylobacter sp. (n = 5), S. enterica (n = 7) and Shigella
sp. (n = 3) and were re-analyzed by either bacterial
culture (for Salmonella sp. and Campylobacter sp.) or by
PCR (for STEC, EPEC, ETEC, EIEC/Shigella, and
EAEC).
Culture of frozen samples for non-spore-forming bac-
terial pathogens and multiplexNAT showed the greatest
discrepancies. Three of seven Salmonella sp. positives
(sensitivity 100 %; specificity 91 %; PPV 43 %; j 0.6;
Table 3) and none of the ETEC-, Campylobacter- and
Shigella-positive samples could be confirmed (n = 17).
The majority of samples did not yield bacterial growth on
enrichment or selective media (n = 11); seven samples
were negative by culture and specific PCR (ETEC, Sal-
monella sp. and Shigella sp.) for the respective pathogen.
The five specimens positive for Campylobacter sp. by
multiplexNAT could not be recovered on selective med-
ium. However, two of three positive multiplexNAT results
from pediatric samples were documented as positive cul-
tures in the patient records. No pathogen was found in any
of the 72 negative control samples.
Co-infections by multiplexNAT
Co-infections were detected in five children and in three
travelers (Table 4). The majority of the multiple infections
included rotavirus (n = 4), followed by ETEC LT/ST
(n = 3), C. difficile (n = 2), norovirus (n = 2) and Giardia
(n = 2). Salmonella sp., Shigella sp. and Campylobacter
sp. were part of mixed infections one time each. Discordant
samples were re-extracted and analyzed for a second time
in the multiplexNAT assay, starting from the frozen
material. In total, 5/8 mixed infections found in the first
round of analysis by multiplexNAT could be confirmed by
PCR, or a repeat multiplexNAT.
Table 3 Comparing multiplexNAT with PCR testing
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
j
Rotavirus 100 100 100 100 1
Adenovirus 100 100 100 100 1
Norovirus 100 42 46 100 0.32
C. difficile 100 100 100 100 1
Salmonella sp. 100 91 43 100 0.6
Cryptosporidium 100 100 100 100 1
G. lamblia 100 56 33 100 0.32
PPV positive predictive value
NPV negative predictive value
j interobserver agreement
Table 4 Co-infections in all samples analyzed by mulitplexNAT
Age (month/
year)
Gender male/
female
Pathogen 1 Pathogen 2
Pediatric patients
2 months M Norovirus Salmonella sp.
6 months M Rotavirus Norovirus
10 months M Rotavirus C. difficile
2 years M Rotavirus C. difficile
2 years W Rotavirus Giardia lamblia
Patients returning from tropics
48 years M ETEC LT/
ST
Shigella sp.
65 years W ETEC LT/
ST
Giardia lamblia
74 years W ETEC LT/
ST
Campylobacter
sp.
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Discussion
In this study, we examined the performance of a com-
mercial multiplexNAT detecting 15 gastroenteritis patho-
gens in 312 consecutive stool samples from two different
patient groups. Overall, pathogens were identified in 87
stool samples (28 %), 66 of which were obtained from
pediatric patients with gastroenteritis. This detection rate of
52 % was significantly higher than the 21 (11 %) in sam-
ples from mostly adult patients with suspected parasite
infestation (p \ 0.0001; Chi square). In the pediatric
samples, the pathogen distribution corresponds to the one
expected for diarrhea in young children [2, 6, 34, 37].
Rotavirus was the most frequently detected pathogen in
pediatric samples (27 %; 34/127 or 52 % of positive
samples), and also most prevalent in co-infections (4/5).
Rotavirus vaccination is not yet part of the standard vac-
cine program in Switzerland, explaining the high preva-
lence of this virus in young children. The multiplexNAT
increased detection rates by 32 % compared to DAD and
validity of the data was confirmed by independent rotavi-
rus-specific PCR, resulting in a PPV of 100 % and j = 1.
With regard to co-infections, the data are in accordance
with other studies [2, 6, 34], where rotavirus was found
prominently in young children with acute gastroenteritis.
Possibly, rotavirus might play a role in conjunction with
primary bacterial or facilitating secondary bacterial infec-
tions [35].
MultiplexNAT also reliably detected other pathogens
i.e. adenovirus, Cryptosporidium sp., C. difficile), yielding
a PPV of 100 %, and an interobserver agreement of j = 1.
Interestingly, C. difficile was detected in 7 % of children’s
samples. C. difficile associated disease is one of the main
causes of nosocomial gastroenteritis [1] and is also linked
to antibiotic-associated diarrhea [18]. However, in a recent
study by Denno et al. [11], the role of C. difficile as
causative agent has been questioned. Despite the increasing
epidemiological importance of community-acquired C.
difficile colitis and the fact that the current molecular
assays focus on toxin gene detection, it remains to be
addressed whether or not children are a relevant commu-
nity reservoir of C. difficile, and if its detection always
warrants treatment.
MultiplexNAT detected a total of eight ETEC-positive
samples, five Campylobacter-positive samples, seven S.
enterica-positive samples, and three Shigella-positive
samples in this study. While culture methods confirmed
three of the seven Salmonella-positive samples (43 %),
they failed to confirm any of the Campylobacter and Shi-
gella results. Of the unconfirmed Salmonella cases, three
showed clinical signs of enteritis and fever. Unfortunately,
for one patient, clinical records were not available. Simi-
larly, the eight multiplexNAT ETEC results could not be
independently found by PCR in an external referral labo-
ratory, since primary enrichment by culture was not suc-
cessful after thawing. Therefore, sensitivity, specificity,
PPV and NPV could not be calculated reliably for these
bacteria. False-positive results in the multiplexNAT or,
more likely to us given the technical limitation, false-
negative results in the external lab might explain this dis-
cordance. Shigella-positive samples were all confirmed by
independent repeats of the mulitplexNAT. Since samples
that were sent in for bacterial examination were frozen at
-80 C, most likely viability was greatly reduced, thereby
contributing to discordant analyses. The positive findings
of some culture-based original patient records described in
the results section for two of three Campylobacter sp.
positive pediatric samples, also support this conclusion. For
Campylobacter sp., it has been reported that freezing [28]
and the age of the culture [32] greatly influence the survival
of non-spore-forming bacteria.
Norovirus was present in 11/66 (15 %) pathogen-posi-
tive children’s specimens and in 4/21 (17 %) positive
traveler’s samples being a most prevalent pathogen in both
patient groups. Incidence rates in children range from 7 to
20 % [13, 19, 21, 23]. Detection rates of norovirus by
multiplexNAT were considerably higher ([50 %) than by
DAD, in line with the well-known lower sensitivity of
DAD assays. However, the PPV for norovirus was only
46 %, with a fair j value of 0.32, when compared with an
external reference PCR. Norovirus-positive specimens
missed by external PCR testing had a wide range of MFI
values in the multiplexNAT suggesting that low viral loads
are less likely causing the discrepancies. Therefore, the
high sequence variability of noroviruses is a contributing
cause of reduced sensitivity. Sequencing of the corre-
sponding norovirus target regions in the discordant samples
might clarify this possibility.
The most common cause of traveler’s diarrhea is
enterotoxigenic E. coli (30–60 % of all cases) [4, 17]. We
detected ETEC in 33 % (7/21) of the positive stool sam-
ples. The second most frequently detected pathogen was
the parasite G. lamblia, which was detected in 5/21 positive
samples (21 %) and in 3 % of samples overall. The prev-
alence in travelers is between 3 and 4 % for Switzerland
(Swiss Tropical and Public Health Institute, Basel, Swit-
zerland). Compared with the multiplexNAT, microscopy,
only one Giardia-positive sample was found by micros-
copy, similar to other reports [7, 39].
No association was seen between Cryptosporidium
infection and travel history. However, cryptosporidiosis
can be linked to public swimming pools and lake water
[20] and young children are known to be particularly sus-
ceptible [8, 25, 26]. In our study, the only confirmed
infection occurred in a pediatric sample from an 8-year-old
girl with no known travel history.
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For the mostly adult patients returning from the tropics
with gastrointestinal symptoms or parasite infestation, the
value of this mulitplexNAT is not as clear as for the
pediatric gastroenteritis group. Microscopy identified 63
positive samples (34 %), whereas multiplexNAT revealed
pathogens in only 21 samples (11 %), five of those being
parasites. Thus, the number of parasites not detectable by
the multiplex approach is relatively high, most of which
are not considered to be typical causes of gastroenteritis.
On the other hand, 16 non-parasitic pathogens (9 %)
would have been missed by microscopy alone. B. hominis
and Endolimax nana are generally considered non-patho-
genic, although they have been found in the stool of
patients presenting with diarrhea. It is presently unre-
solved, whether these agents should be included in a
multiplex panel. Our preliminary results on immunodefi-
cient adult patients with diarrhea identified a higher
detection rate of 29 % with norovirus (10 %), C. difficile
(4 %), and Campylobacter sp. (4 %). A similar distribu-
tion in immunodeficient patients with norovirus and
Campylobacter sp. being the primary pathogens detected,
has been observed by Coste et al. [10] and is emphasized
in a recent review [12].
MultiplexNAT has a turnaround time (TAT) of
approximately 6 h, after which the results for 15 infectious
agents are available in the electronic lab information sys-
tem. By comparison, culture can take several days (at least
48 h) and has a high hands-on-time. This is similar for
microscopy, but typically multiple consecutive specimens
are needed to diagnose a parasitic infection. Only DAD is
faster than multiplexNAT, but the sensitivity, as shown in
this study, is typically lower.
MultiplexNAT permits parallel testing of different
pathogens and 20–40 patients are easily handled. Com-
bined with automated extraction, we estimate the hands-on-
time as being 2 h to generate 300 separate results for 20
patients. This approach also justifies higher costs (approx.
60 € of material per patient) of the multiplexNAT com-
pared to conventional methods. DAD also has significant
kit costs and shares a higher hands-on-time with micros-
copy. Clearly, the multiplexNAT requires the expertise of a
molecular diagnostic laboratory with skilled personnel and
is therefore not suitable as a point of care test. For urgent
testing, other assays like DAD would be desirable.
For children with gastroenteritis, DAD is done first, and
if found negative, or additional pathogens are clinically
suspected, multiplexNAT is performed. For patients
returning from the tropics, we would recommend to restrict
multiplexNAT to patients with the clinical diagnosis of
gastroenteritis. For immunocompromised patients or
patients with a broad differential diagnosis, multiplexNAT
could provide results rapidly that have an impact on the
clinical management, e.g. infection control, cohorting,
empiric therapy, resulting in reduced hospital stay and
costs. In a second step, targeted tests can be added, e.g.
antibiotic resistance, if needed.
Our study has some limitations: not all samples were
tested by all methods. Because of the higher sensitivity of
multiplexNAT, we selected positive samples and a random
selection of 72 negative samples for independent confir-
mation. Second, we did not obtain positive results for all
multiplexNAT targets. For example, the ability to detect V.
cholerae or Y. enterocolitica could not be examined in our
consecutive stool specimens. However, external quality
control programs and other publications [10, 27] strongly
suggest a reasonable sensitivity. If these pathogens are
suspected, we currently recommend using standard meth-
ods in addition to multiplexNAT.
Taken together, multiplexNAT can reduce the turn-
around time and minimize hands-on-time and the need for
splitting the specimens for parallel testing. Currently, we
see the major role of multiplexNAT for patients with a
broad differential diagnosis, especially when rapid results
are needed. In fact, we reported a recent case of a hema-
topoietic stem cell transplant patient with multifactorial
diarrhea, where the Shiga toxin-producing E. coli O51:H49
was first detected by multiplexNAT, which later developed
a hemolytic uremic syndrome (HUS) with a fatal outcome
[14]. To fully estimate the clinical importance of multi-
plexNAT, prospective studies are needed that address the
role for diagnosis, infection control and empiric manage-
ment of gastroenteritis patients.
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